Who is sponsoring NCT05214079?

NCT05214079 is sponsored by University of Liege.

What drugs are being tested in NCT05214079?

Interventions in NCT05214079: Left paratracheal pressure.

What condition does NCT05214079 study?

NCT05214079 studies Oesophageal Reflux.

Is NCT05214079 still recruiting?

NCT05214079 is currently status unknown. Last updated 28 January 2022.

Last reviewed 2022-01-28 · How we verify

NCT05214079

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determination of the Left Paratrachéal Force Required to Occlude the Esophageal Entrance

Status unknown NA Last updated 28 January 2022

What this trial tests

NA trial testing Left paratracheal pressure in Oesophageal Reflux in 100 participants. Status unknown.

Timeline

1 March 2022

Primary endpoint
30 July 2022

1 September 2022

Quick facts

Lead sponsor	University of Liege
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	100
Start date	1 March 2022
Primary completion	30 July 2022
Estimated completion	1 September 2022

Drugs / interventions tested

Left paratracheal pressure

Conditions studied

Oesophageal Reflux — all drugs for Oesophageal Reflux →

Sponsor

University of Liege

Who can join

Adults 18 to 80, any sex, with Oesophageal Reflux. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determine the force required to occlude the esophagus with a left paratracheal pressure

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05214079 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 28 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05214079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing